X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SANOFI INDIA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SANOFI INDIA NOVARTIS/
SANOFI INDIA
 
P/E (TTM) x 347.8 30.3 1,147.4% View Chart
P/BV x 17.1 5.4 319.9% View Chart
Dividend Yield % 1.7 1.7 100.0%  

Financials

 NOVARTIS   SANOFI INDIA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
SANOFI INDIA
Dec-16
NOVARTIS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs9824,560 21.5%   
Low Rs5564,400 12.6%   
Sales per share (Unadj.) Rs252.91,028.5 24.6%  
Earnings per share (Unadj.) Rs62.1129.0 48.2%  
Cash flow per share (Unadj.) Rs63.3186.0 34.0%  
Dividends per share (Unadj.) Rs10.0068.00 14.7%  
Dividend yield (eoy) %1.31.5 85.7%  
Book value per share (Unadj.) Rs363.6753.6 48.2%  
Shares outstanding (eoy) m31.9623.03 138.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.04.4 69.8%   
Avg P/E ratio x12.434.7 35.6%  
P/CF ratio (eoy) x12.224.1 50.4%  
Price / Book Value ratio x2.15.9 35.6%  
Dividend payout %16.152.7 30.5%   
Avg Mkt Cap Rs m24,580103,174 23.8%   
No. of employees `0000.83.6 20.8%   
Total wages/salary Rs m1,8013,592 50.1%   
Avg. sales/employee Rs Th10,748.96,537.7 164.4%   
Avg. wages/employee Rs Th2,395.2991.4 241.6%   
Avg. net profit/employee Rs Th2,641.1819.8 322.2%   
INCOME DATA
Net Sales Rs m8,08323,686 34.1%  
Other income Rs m829708 117.1%   
Total revenues Rs m8,91324,394 36.5%   
Gross profit Rs m2345,281 4.4%  
Depreciation Rs m371,313 2.8%   
Interest Rs m215 12.0%   
Profit before tax Rs m1,0254,661 22.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m7521,691 44.5%   
Profit after tax Rs m1,9862,970 66.9%  
Gross profit margin %2.922.3 13.0%  
Effective tax rate %73.436.3 202.2%   
Net profit margin %24.612.5 196.0%  
BALANCE SHEET DATA
Current assets Rs m12,67815,673 80.9%   
Current liabilities Rs m2,4336,678 36.4%   
Net working cap to sales %126.738.0 333.7%  
Current ratio x5.22.3 222.0%  
Inventory Days Days3376 43.0%  
Debtors Days Days2222 100.8%  
Net fixed assets Rs m698,098 0.9%   
Share capital Rs m160230 69.4%   
"Free" reserves Rs m11,46017,088 67.1%   
Net worth Rs m11,62117,356 67.0%   
Long term debt Rs m00-   
Total assets Rs m14,40025,400 56.7%  
Interest coverage x570.5311.7 183.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 60.2%   
Return on assets %13.811.8 117.5%  
Return on equity %17.117.1 99.9%  
Return on capital %23.626.9 87.5%  
Exports to sales %0.724.5 3.0%   
Imports to sales %18.628.0 66.4%   
Exports (fob) Rs m605,801 1.0%   
Imports (cif) Rs m1,5036,627 22.7%   
Fx inflow Rs m1867,145 2.6%   
Fx outflow Rs m1,8216,846 26.6%   
Net fx Rs m-1,635299 -546.7%   
CASH FLOW
From Operations Rs m2,5313,226 78.5%  
From Investments Rs m-8,270-1,555 531.8%  
From Financial Activity Rs m-386-1,818 21.2%  
Net Cashflow Rs m-6,125-147 4,166.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 2.0 14.4 13.9%  
FIIs % 1.6 14.6 11.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 10.5 204.8%  
Shareholders   41,647 15,184 274.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DR. REDDYS LAB  IPCA LABS  ALKEM LABORATORIES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 18, 2017 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS